GLUTATHIONE 200MG/ML — Class II drug recall D-1663-2019
Terminated recall by RXQ Compounding LLC, reported 2019-08-14, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-1663-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RXQ Compounding LLC, Athens, OH, United States |
| Recall initiated | 2019-06-19 |
| Classified | 2019-08-08 |
| Reported by FDA | 2019-08-14 |
| Terminated | 2022-09-16 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| NDC | 70731-0906-30 |
Product
GLUTATHIONE 200MG/ML (MDV) INJECTION SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0906-30
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1663-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.